Arkolith/Insider Trading/AYTU/Form 4

Disbrow Joshua R.

Chief Executive Officer, DirectorAYTU BIOPHARMA, INC (AYTU) · full profile →Form 4 · filed Dec 21, 2022
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2022Buy(P)112K$0.22$25K1.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-021900) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML